Medical Equipment

Global Brain Mapping Instruments Market Valuation and Growth Prospects: $3.13 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the brain mapping instruments market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Brain Mapping Instruments Market Size?

The brain mapping instruments market has experienced substantial growth in recent years. It is anticipated to expand from $2.27 billion in 2024 to $2.42 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historical growth can be attributed to the increasing prevalence of neurological disorders, rise in demand for real-time brain monitoring, growth in clinical trials, growth of brain mapping in psychiatry, and expansion of telemedicine.

The brain mapping instruments market is anticipated to experience robust expansion in the near future, set to reach $3.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. This projected growth during the forecast period is driven by factors such as the escalating demand for advanced neuroimaging techniques, increasing investments in neuroscience research, the expanding adoption of non-invasive brain mapping technologies, a rising number of clinical trials, and a growing need for brain mapping in educational and cognitive development studies. Prominent trends expected in this period include ongoing technological advancements, the integration of virtual reality, the evolution of personalized medicine, new non-invasive brain mapping techniques, and the application of cloud computing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp

What Core Market Drivers Are Expanding The Brain Mapping Instruments Industry?

The growing occurrence of neurological conditions is anticipated to fuel the expansion of the brain mapping instrument market. These disorders involve impairments of the brain, spinal cord, and nerves, manifesting in symptoms like impaired movement, reduced cognitive function, and sensory disturbances, with common examples being Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. Several factors contribute to the rising incidence of neurological disorders, including an aging global population, increased urbanization, evolving lifestyles, advancements in diagnostic methods, and various environmental and infectious risks. Brain mapping instruments are crucial for both clinical applications and research, offering profound understanding of neurological disorders and facilitating tailored treatment approaches. For example, data from March 2023 reported by the Alzheimer’s Association, a US-based non-profit voluntary health organization, indicated that approximately 6.7 million Americans aged 65 and older in the United States were affected by Alzheimer’s dementia, a form of neurological disorder. Furthermore, projections suggest that by 2060, this figure for individuals aged 65 and older living with Alzheimer’s dementia will rise to 13.8 million. Consequently, the expanding prevalence of neurological conditions serves as a significant impetus for the growth of the brain mapping instrument market.

What Segment Insights Are Highlighted In The Brain Mapping Instruments Market Report?

The brain mapping instrumentsmarket covered in this report is segmented –

1) By Product: Computed Axial Tomography (CAT), Positron Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (FNIRS), Functional Magnetic Resonance Imaging (FMRI), Other Products

2) By Procedure: Devices For Invasive Procedures, Devices For Non-invasive Procedures

3) By End User: Hospitals, Ambulatory Centers

Subsegments:

1) By Computed Axial Tomography (CAT): Conventional CT Scanners, High-Resolution CT Scanners, Portable CT Scanners

2) By Positron Emission Tomography (PET): PET Scanners (Standalone), Hybrid PET/CT Scanners, PET/MRI Scanners

3) By Electroencephalography (EEG): Digital EEG Systems, Ambulatory EEG Systems, Video EEG Monitoring Systems

4) By Functional Near-Infrared Spectroscopy (FNIRS): Continuous Wave Fnirs Systems, Frequency Domain Fnirs Systems, Hybrid Fnirs Systems

5) By Functional Magnetic Resonance Imaging (FMRI): Resting-State Fmri, Task-Based Fmri, High-Field MRI Systems

6) By Other Products: Magnetoencephalography (MEG) Systems, Near-Infrared Spectroscopy (NIRS) Devices, Transcranial Magnetic Stimulation (TMS) Systems

Which Notable Trends Are Transforming The Brain Mapping Instruments Market Outlook?

Leading corporations within the brain mapping instrument market are concentrating on developing groundbreaking products, such as brain mapping devices, aimed at improving diagnostic accuracy and the effectiveness of treatment for neurological conditions. These brain mapping devices are instruments employed to visualize and analyze the structure and function of the brain. They incorporate various techniques including magnetic resonance imaging (MRI), functional MRI (fMRI), electroencephalography (EEG), magnetoencephalography (MEG), and positron emission tomography (PET). For example, in August 2022, IBS Hospital, an India-based hospital specializing in Neurology, introduced Quicktome, which stands as the first brain mapping device. This innovative technology merges advanced MRI and EEG capabilities with real-time functional imaging, delivering unparalleled precision in depicting brain structure and activity. Its significant features comprise high-resolution imaging for detailed anatomical mapping, simultaneous EEG recording for extensive neural activity monitoring, and functional MRI for dynamic brain function analysis.

Which Firms Are Driving Innovation Within The Brain Mapping Instruments Market?

Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Ricoh Company Ltd., Philips Healthcare, Bio-Rad Laboratories Inc., Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Laureate Digital Securities Pvt Ltd., Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report

What Regional Trends Are Shaping Growth In The Brain Mapping Instruments Market?

North America was the largest region in the brain mapping instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18270&type=smp

Browse Through More Reports Similar to the Global Brain Mapping Instruments Market 2025, By The Business Research Company

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Brain And Neuroimaging Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-and-neuroimaging-devices-global-market-report

Brain Tumor Drugs Global Market 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795